| 000 | 01355 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250512235158.0 | ||
| 264 | 0 | _c19830826 | |
| 008 | 198308s 0 0 eng d | ||
| 022 | _a0190-9622 | ||
| 024 | 7 |
_a10.1016/s0190-9622(83)80010-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aElewski, B E | |
| 245 | 0 | 0 |
_aIn vivo suppression of neutrophil chemotaxis by systemically and topically administered tetracycline. _h[electronic resource] |
| 260 |
_bJournal of the American Academy of Dermatology _cJun 1983 |
||
| 300 |
_a807-12 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnti-Inflammatory Agents |
| 650 | 0 | 4 |
_aChemotaxis, Leukocyte _xdrug effects |
| 650 | 0 | 4 | _aDepression, Chemical |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 |
_aSkin _xdrug effects |
| 650 | 0 | 4 |
_aTetracycline _xadministration & dosage |
| 700 | 1 | _aLamb, B A | |
| 700 | 1 | _aSams, W M | |
| 700 | 1 | _aGammon, W R | |
| 773 | 0 |
_tJournal of the American Academy of Dermatology _gvol. 8 _gno. 6 _gp. 807-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0190-9622(83)80010-3 _zAvailable from publisher's website |
| 999 |
_c6863379 _d6863379 |
||